Lichen planus - I-Lichen Planus
☆ Emiphumeleni ka-2022 ye-Stiftung Warentest evela eJalimane, ukwaneliseka kwabathengi nge-ModelDerm bekungaphansi kancane kunokuxhumana okukhokhelwayo kwe-telemedicine.
Izilonda ezibanzi kuzo zombili izinqe azifani. Kulokhu, ezinye izifo ezingalapheki zokungezwani komzimba (lichen simplex chronicus) zivame ukusolwa kakhulu.
Atrophic lichen planus
References
I- Lichen planus (LP) yisimo sokuvuvukala esihlala isikhathi eside esithinta kakhulu abantu abadala abaphakathi neminyaka yabo ephakathi. Ingabonakala esikhumbeni noma kulwelwesi lwamafinyila njengomlomo, isitho sangasese sowesifazane, umphimbo, ibhokisi lezwi, nolwelwesi lwamehlo. I-LP iza ngezinhlobo ezahlukene kuye ngokuthi ama-rashes abukeka kanjani nokuthi avela kuphi. Ucwaningo luphakamisa ukuthi izinhlobo ezithile ze-LP, njengalezo ezithinta umminzo noma amehlo, zingase zingatholakali ngokwanele. Ezinye izinhlobo ze-LP, njengezinhlobo ze-hypertrophic kanye ne-erosive emlonyeni, zingaba umthwalo ikakhulukazi futhi zihlale isikhathi eside. Ezinye izici ezifana nemithi noma ukuthintana nezinto ezithile kungase kubangele ukuqubuka okubukeka ngendlela efanayo.
Lichen planus (LP) is a chronic inflammatory disorder that most often affects middle-aged adults. LP can involve the skin or mucous membranes including the oral, vulvovaginal, esophageal, laryngeal, and conjunctival mucosa. It has different variants based on the morphology of the lesions and the site of involvement. The literature suggests that certain presentations of the disease such as esophageal or ophthalmological involvement are underdiagnosed. The burden of the disease is higher in some variants including hypertrophic LP and erosive oral LP, which may have a more chronic pattern. LP can significantly affect the quality of life of patients as well. Drugs or contact allergens can cause lichenoid reactions as the main differential diagnosis of LP.
Lichen planus (LP) is a chronic inflammatory disorder that most often affects middle-aged adults. LP can involve the skin or mucous membranes including the oral, vulvovaginal, esophageal, laryngeal, and conjunctival mucosa. It has different variants based on the morphology of the lesions and the site of involvement. The literature suggests that certain presentations of the disease such as esophageal or ophthalmological involvement are underdiagnosed. The burden of the disease is higher in some variants including hypertrophic LP and erosive oral LP, which may have a more chronic pattern. LP can significantly affect the quality of life of patients as well. Drugs or contact allergens can cause lichenoid reactions as the main differential diagnosis of LP.
I- Lichen planus yisimo sesikhumba esimakwa ngamaqhubu aluhlaza, ayisicaba kanye nama-patches angabangela ukulunywa okukhulu. Lezi zilonda zesikhumba zingacindezela, ikakhulukazi uma zithinta umlomo noma izitho zangasese kakhulu. Ezimeni ezimbi kakhulu, oral lichen planus ingase inyuse ngisho nengozi yokuba nohlobo lomdlavuza wesikhumba. Kungase futhi kuthinte isikhumba sekhanda nezinzipho. Nakuba imbangela yezimo eziningi ingaziwa, ezinye zingase zibangelwe imithi ethile noma ukutheleleka nge-hepatitis C. Ukwelashwa kuvame ukubandakanya okhilimu abaqinile bezehlakalo zasendaweni kanye nama-oral steroids asabalele kakhulu.
Lichen planus is a skin condition marked by purplish, flat-topped bumps and patches that can cause intense itching. These skin lesions can be distressing, especially when they affect the mouth or genitals severely. In severe cases, oral lichen planus may even increase the risk of developing a type of skin cancer. It can also affect the scalp and nails. While the cause of most cases is unknown, some may be triggered by certain medications or hepatitis C infection. Treatment typically involves strong creams for localized cases and oral steroids for more widespread ones.
Lichen planus is a skin condition marked by purplish, flat-topped bumps and patches that can cause intense itching. These skin lesions can be distressing, especially when they affect the mouth or genitals severely. In severe cases, oral lichen planus may even increase the risk of developing a type of skin cancer. It can also affect the scalp and nails. While the cause of most cases is unknown, some may be triggered by certain medications or hepatitis C infection. Treatment typically involves strong creams for localized cases and oral steroids for more widespread ones.
Lichen planus yisimo lapho amasosha omzimba ebanga ukuvuvukala, okuholela emakhazeni ahlukile esikhumbeni kanye nolwelwesi lwamafinyila. Ithinta cishe u-5% wabantu abadala, ngokuvamile abesifazane, futhi ngokuvamile iqala phakathi neminyaka ephakathi. Ukuzibandakanya ngomlomo kubonakala ku-77% wamacala, ikakhulukazi athinta isihlathi sangaphakathi. Nakuba abanye abantu bengase bangezwa noma yiziphi izimpawu, abanye bangase bezwe ubuhlungu futhi babe nenkinga ngokudla okuthile (isb. , okune-acidic, okubabayo) noma umuthi wokuxubha amazinyo.
Lichen planus is an immune-mediated inflammatory condition leading to characteristic lesions on skin and mucous membranes. It presents in up to 5% of the general adult population with a female predilection (2:1); the onset is most commonly in middle age. Up to 77% of patients with lichen planus have oral disease, with buccal mucosa the most common subsite. The oral lesions may be asymptomatic, although a subset of patients have pain and difficulty tolerating certain foods (e.g., acidic, spicy) and toothpaste.
Lichen planus is an immune-mediated inflammatory condition leading to characteristic lesions on skin and mucous membranes. It presents in up to 5% of the general adult population with a female predilection (2:1); the onset is most commonly in middle age. Up to 77% of patients with lichen planus have oral disease, with buccal mucosa the most common subsite. The oral lesions may be asymptomatic, although a subset of patients have pain and difficulty tolerating certain foods (e.g., acidic, spicy) and toothpaste.
Ukuqinisekisa ukuxilongwa kwe-cutaneous lichen planus, i-biopsy yesikhumba ingenziwa. I-Direct immunofluorescence (DIF) ingaba usizo ezigulini ezinezilonda zenkunzi ukuze zihlukanise isimo sesifo se-autoimmune vesiculobullous.